Fundraising FoxVertis SGR — Full Portfolio
13 tracked investments · listed companies and verified rows first
Sibylla Biotech develops PPI-FIT, a drug discovery technology that uses quantum physics and mathematical modeling to characterize protein folding pathways at atomic resolution.
AI & Machine LearningBiotechDeep TechTrento, IT
Emiliano Biasini(Co-founder)inPietro Faccioli(Co-founder)inGiovanni Spagnolli(Co-founder, CTO)inMaria Letizia Barreca(Co-founder)inGraziano Lolli(Co-founder)
Co-investors3B Future Health FundCDP Venture CapitalSeroba Life SciencesV-Bio VenturesVI PartnersClaris Ventures+1 more
Aindo generates synthetic clinical data and specialized clinical language models that let healthcare organizations, pharma companies, CROs, and public administrations run analyses, observational studies, and Real World Evidence generation without exposing patient-level data.
AI & Machine LearningDigital HealthHealthtech
Daniele Panfilo(Founder)Borut Svara(Founder)Sebastiano Saccani(Founder)
Co-investorsUnited Ventures
Fitprime offers wellness solutions aimed at building healthier habits and connecting work with well-being, positioning itself as a bridge between the workplace and health.
Future of WorkHealthtechHR TechSaaSWellness & Fitness
Co-investorsItalian Angels for GrowthLVenture GroupClub degli Investitori
A company applying artificial intelligence to healthcare screening programs, aimed at medical professionals.
AI & Machine LearningDigital HealthHealthtech
MetLife's Italian operation, part of the global MetLife insurance group, provides life, personal protection, and creditor-protection insurance products through independent distribution, bancassurance and partnerships, and direct-to-consumer channels in Italy.
FintechInsurTech
Adriano De Matteis(General Manager, MetLife Italia)inAna Ramírez Muñiz(Head of HR, Southern Europe)Marco Mucci(Director of Independent Distribution, Italy)inStefania Pagani(Bancassurance Director)Riccardo Mucci(Director of Direct To Consumer channel)inLaura Balla(Head of Marketing & Communication, Italy)
Co-investorsMetLife Investment ManagementTencent Holdings
Mistral builds and open-sources frontier AI models, developer tools, and applications for organizations in finance, manufacturing, defense, energy, and the public sector to solve complex problems.
AI & Machine LearningCloud ComputingDeveloper ToolsEnterprise SoftwareParis, FR
Arthur Mensch(Founder)inGuillaume Lample(Founder)inTimothee Lacroix(Co-founder and CTO)inTimothée Lacroix(Founder)
Co-investors83NorthAndreessen HorowitzBalderton CapitalCisco InvestmentsConvictionElad Gil+46 more
.jpeg)
Radical Aero builds StratoSats, autonomous solar-powered aircraft that operate at 65,000 feet for extended periods to deliver persistent high-performance infrastructure.
Advanced ManufacturingDeep TechDefense TechHardwareSpace TechSeattle, US
James Thomas(Founder)inCyriel Notteboom(Founder)inSimone Jensen(Founder)
Co-investorsInflection.xyzScout VenturesScout VenturesY CombinatorAndreessen HorowitzBessemer Venture Partners+4 more
Wellhub operates a corporate wellness platform that connects employees to fitness, mindfulness, nutrition, and sleep options through employer-provided plans.
Digital HealthHR TechWellness & FitnessNew York, US
Vinicius Meirelles Ferriani(Director)Joao Barbosa(Director)inCesar Carvalho(Founder)inCesar Carvalho (he/his)(Founder)inBruno Annicq(Executive Officer)inEllen Hochberg(Executive Officer)in
Co-investorsAtomicoGeneral AtlanticHeadlineInkefKaszek VenturesMONASHEES+9 more
Zerynth provides an industrial technology ecosystem that connects factory machines through IoT hardware, edge computing, and ERP/MES integration, plus an AI copilot ("Zero") that analyzes real-time production data to deliver insights and reduce downtime.
Advanced ManufacturingAI & Machine LearningIoTPisa, IT
Co-investorsCDP Venture CapitalLIFTTUnited Ventures
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
NewtwenQuidoScuterSoource
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.